Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Dow
Moodys
Express Scripts
Baxter

Last Updated: December 6, 2021

DrugPatentWatch Database Preview

Patent: 8,277,830

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 8,277,830
Title:Posterior segment drug delivery
Abstract: A therapeutic device to release a therapeutic agent comprises a porous structure coupled to a container comprising a reservoir. The reservoir comprises a volume sized to release therapeutic amounts of the therapeutic agent for an extended time when coupled to the porous structure and implanted in the patient. The porous structure may comprise a first side coupled to the reservoir and a second side to couple to the patient to release the therapeutic agent. A plurality of interconnecting channels can extend from the first side to the second side so as to connect a first a plurality of openings on the first side with a second plurality of openings on the second side.
Inventor(s): de Juan, Jr.; Eugene (Menlo Park, CA), Alster; Yair (Menlo Park, CA), Farinas; Kathleen Cogan (Menlo Park, CA), Gifford, III; Hanson S. (Menlo Park, CA), MacFarlane; K. Angela (Menlo Park, CA), Reich; Cary J. (Menlo Park, CA), Barrett; Michael (Menlo Park, CA), Campbell; Randolph E. (Menlo Park, CA), Sutton; Douglas (Menlo Park, CA)
Assignee: ForSight Vision4, Inc. (Menlo Park, CA)
Application Number:13/252,998
Patent Claims:see list of patent claims

Details for Patent 8,277,830

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Emd Serono, Inc. PERGONAL menotropins For Injection 017646 1975-08-22 ⤷  Free Forever Trial 2029-01-29
Emd Serono, Inc. PERGONAL menotropins For Injection 017646 1985-05-20 ⤷  Free Forever Trial 2029-01-29
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 1987-06-23 ⤷  Free Forever Trial 2029-01-29
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 1986-10-16 ⤷  Free Forever Trial 2029-01-29
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 1999-02-04 ⤷  Free Forever Trial 2029-01-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Moodys
Baxter
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.